CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Michal Zimmermann(Mount Sinai Hospital), Olga Murina(University of Edinburgh), Martin A.M. Reijns(University of Edinburgh), Angelo Agathanggelou(University of Birmingham), Rachel Challis(Institute of Genetics and Cancer), Žygimantė Tarnauskaitė(University of Edinburgh), Morwenna Muir(Edinburgh Cancer Research), Adeline Fluteau(Institute of Genetics and Cancer), Michael Aregger(University of Toronto), Andrea McEwan(Mount Sinai Hospital), Wei Yuan(Institute of Cancer Research), Matthew Clarke(Institute of Cancer Research), Maryou B. Lambros(Institute of Cancer Research), Shankara Paneesha(Heartlands Hospital), Paul Moss(University of Birmingham), Megha Chandrashekhar(University of Toronto), Stéphane Angers(University of Toronto), Jason Moffat(Canadian Institute for Advanced Research), Valerie G. Brunton(Edinburgh Cancer Research), Traver Hart(The University of Texas MD Anderson Cancer Center), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Tatjana Stanković(University of Birmingham), Andrew P. Jackson(Institute of Genetics and Cancer), Daniel Durocher(University of Toronto)
Nature
July 1, 2018
10.1038/s41586-018-0291-z
Cited by 415Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis